Vaccines

ICAR-CIBA has launched a recombinant vaccine against viral nervous necrosis (VNN), in a milestone for aquaculture vaccine development in India.

Eight urban aquaculture projects are among the 12 projects chosen to receive a share of $23 million in funding from the Singapore Food Agency (SFA).

Researchers are optimistic about the possibility of developing an oral vaccine against francisellosis in tilapia, following promising trials in Thailand.

New research from the University of Aberdeen could allow the development of drugs and vaccines to treat a disease that is rapidly emerging in aquaculture as a result of climate change.

The provision of safe and effective vaccination programmes is one of the key tools to ensure the sustainable development of the aquaculture sector and therefore help meet growing global protein demands.

An oral vaccine that protects tilapia from Streptococcusinfection is due to be trialled on farms before the end of the year.

Plans to develop a new range of novel algae-based vaccines that can be delivered orally to animals including farmed fish and shrimp have been given a boost by the completion of a new partnership.

Investment firms in the aquaculture sector are looking at the seafood industry’s broader canvas for profits instead of solely focusing on biomass.

Vaccines based on synthetic DNA rather than whole viruses could offer the aquaculture sector a novel and relatively economical means for tackling a range of diseases across species.

A new aquaculture vaccine development company has been launched by Touchlight Genetics and Stonehaven Incubate.

Benchmark is selling its vaccine manufacturing facility as part of a £100 million UK government project to mass produce a vaccine against Covid-19.

A new line of syringes from Socorex has been launched for a variety of sectors including aquaculture.

Trials of a new vaccine against infectious pancreatic necrosis virus (IPNV) in rainbow trout have shown promising results.

Norwegian salmon were given 397 doses of vaccines in 2019 - 28 million more than the previous year.

Plans to develop and launch a “transformational” fish vaccinating robot by the end of next year have been boosted by a £250,000 grant.

A polyvalent vaccine can help to protect both tilapia broodstock and their offspring from the effects of Streptococcus agalactiae, according to a new study.

A project to develop a pioneering oral vaccine to protect salmon from sea lice has just been launched in Scotland.

MSD Animal Health has released Aquavac, a strep sa-si vaccine that provides long-lasting protection against disease due to streptococcis.

The Aquaculture Innovation Showcase is coming in September. Ahead of the event in London, The Fish Site spoke to TransAlgae’s VP of research and development, Ofra Chen, to discuss how algae can revolutionise the health a…

Market forecasters estimate that the sector will reach $336 million by 2026.